Korean securities watchdog has requested to review whether the company should be delisted and recommended the dismissal of its CEO.
Authorities in China are proposing new fines specific to vaccine manufacturers after scandals rocked public trust in vaccines in the country.
Merck is increasing its HPV vaccine production capacity, but it still won't be enough to meet the full demand in China, a company spokesperson said.
Novo said it cracked down on the wholesaler through its local distributor Zuellig Pharma Korea, which terminated the alleged smuggler’s contract.
Big Pharma firms touted growth in China; Genentech sues ex-staffers and biosim company; Janssen licenses Yuhan's potential Tagrisso rival.
Hikma, which has established itself as a top sterile injectables manufacturer in the U.S., is now picking up a production plant in Vietnam.
Ex-Roche scientists were charged with stealing trade secrets; Astellas invested in gene and cell therapy; Takeda touted growth in key focus areas.
Merck's RotaTeq won China approval in April and a launch is underway, but meanwhile, the company is reducing its shipments to low-income countries.
The FDA says a probable cancer-causing ingredient has been found in yet another blood pressure treatment in the U.S.
The FDA continues to find issues with Dr. Reddy’s oncology formulation facility at Duvvada, one of three cited in a warning letter.